These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5940924)

  • 1. Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo.
    Fitzpatrick TB; Arndt KA; el-Mofty AM; Pathak MA
    Arch Dermatol; 1966 May; 93(5):589-600. PubMed ID: 5940924
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of psoberan in vitiligo].
    Mirakhmedov UM; Abidov MM
    Vestn Dermatol Venerol; 1976 Feb; (2):77-9. PubMed ID: 936777
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of hydroquinone as a bleaching cream.
    Yi K; Hart LL
    Ann Pharmacother; 1993 May; 27(5):592-3. PubMed ID: 8347912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the mechanism of psoralens in the treatment of vitiligo].
    Rudowska I
    Przegl Dermatol; 1965; 52(4):391-6. PubMed ID: 5832591
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the effectiveness of vitiligo treatment with psoralens; studies of the action mechanism].
    Rudowska I
    Asthet Med (Berl); 1968 May; 17(5):117-24. PubMed ID: 4180779
    [No Abstract]   [Full Text] [Related]  

  • 6. [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
    Heilgemeir GP; Balda BR
    MMW Munch Med Wochenschr; 1981 Jan; 123(2):47-8. PubMed ID: 6782448
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitiligo--treatment with trimethylpsoralen.
    Bleehen SS
    Br J Dermatol; 1971 Feb; 84(2):186-8. PubMed ID: 5548475
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    Oakley AM
    Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current points of view on the therapy of vitiligo].
    Ormea F
    Minerva Med; 1974 Apr; 65(30):1653-64. PubMed ID: 4833771
    [No Abstract]   [Full Text] [Related]  

  • 10. Some biochemical and chemotherapeutic aspects of vitiligo.
    Chakraborty DP
    Indian J Dermatol; 1966 Apr; 11(3):69-75. PubMed ID: 5945820
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospects of the use of preparations of the psoralen group in the treatment of vitiligo patients].
    Zheltakov MM; Vinokurov IN
    Sov Med; 1966 Aug; 29(8):110-5. PubMed ID: 5991379
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience in the use of a psoberan preparation in patients with vitiligo and alopecia].
    Braĭtsev AV
    Vestn Dermatol Venerol; 1975 Sep; (9):53-5. PubMed ID: 1231363
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Trioxsalen therapy for vitiligo.
    Sehgal VN
    Arch Dermatol; 1974 Apr; 109(4):578. PubMed ID: 4819131
    [No Abstract]   [Full Text] [Related]  

  • 14. A case report of extensive vitiligo.
    Wee TA
    Hawaii Med J; 1997 Feb; 56(2):37-40. PubMed ID: 9063009
    [No Abstract]   [Full Text] [Related]  

  • 15. Corneal and conjunctival effects of monobenzone in patients with vitiligo.
    Hedges TR; Kenyon KR; Hanninen LA; Mosher DB
    Arch Ophthalmol; 1983 Jan; 101(1):64-8. PubMed ID: 6849655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of the efficacy of a topical preparation containing 2% hydroquinone in chloasma].
    Melli MC
    G Ital Dermatol Venereol; 1987 Dec; 122(12):LXV-LXVII. PubMed ID: 3447991
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and morphological study of the skin in patients with vitiligo during treatment with psoralen].
    Arutiunov VIa; Arkhangel'skaia NV; Uzhvieva NV
    Vestn Dermatol Venerol; 1972 Feb; 46(2):8-12. PubMed ID: 5036805
    [No Abstract]   [Full Text] [Related]  

  • 18. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
    Mosher DB; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of hypermelanosis with 4-isopropylcatechol.
    Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):687-94. PubMed ID: 949461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [4-5-8 trimethylpsoralen in vitiligo. Controlled study of its therapeutic and toxic effect in children].
    Ruíz Maldonado R; Tamayo Sánchez L
    Actas Dermosifiliogr; 1975; 66(9-10):513-26. PubMed ID: 1199825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.